ReviewCardiovascular therapeutics2026
Atorvastatin Safety Reappraised: From Pharmacogenomic Mechanisms to Personalized Risk Management.
Hanyu Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it